Mondelez International (NASDAQ: MDLZ) can look like two different investments depending on which number an investor starts with. Second-quarter 2026 reported revenue and organic sales increased, and volume/mix returned to growth. Reported diluted earnings per share surged 144.9%. Yet adjusted EPS was flat in reported currency and declined on a constant-currency basis, while the adjusted operating margin narrowed. That split helps explain why a favorable earnings headline does not automatically produce a lasting uptrend in the stock.

MDLZ closed at $59.46 on October 6, 2026, after finishing September 30 at $57.82. The six-day rebound was about 2.8%, but the close remained below the $64.99 close on July 29, the day after the company reported Q2 results. A few sessions can show a bounce; they cannot establish that investors have repriced the business for durable earnings growth. This article uses historical closes through October 6, not a live quote. Check the company’s historical stock quote page for updated data.

Food production workers inspect rows of chocolate pieces moving along a stainless-steel conveyor
Workers inspect chocolate pieces on a production line, illustrating the manufacturing and input-cost side of Mondelez’s business.

What the latest results say about MDLZ

Mondelez reported Q2 2026 on July 28 for the quarter ended June 30. Net revenue increased 4.1% to $9.355 billion. Organic net revenue, a company-defined non-GAAP measure that excludes certain currency, acquisition, and divestiture effects, grew 2.2%. Within that organic growth, pricing contributed 1.5 percentage points and volume/mix contributed 0.7 points. Positive volume/mix is a constructive signal because it indicates the sales result was not coming from price increases alone. It does not, by itself, prove that the company can raise prices without consumer pushback.

The reported earnings figure needs more context. Diluted EPS rose to $1.20 from $0.49 a year earlier, but adjusted EPS was $0.73, flat year over year in reported currency and down 2.7% on a constant-currency basis. Mondelez attributed the gap in part to year-over-year changes in mark-to-market impacts from commodity and foreign-currency derivatives, lower pension participation charges, and tax-law effects. Those factors affect reported earnings, but they do not measure recurring operating progress in the same way as adjusted profit.

Margins tell a similarly mixed story. Reported operating margin rose to 20.8%, helped substantially by derivative mark-to-market effects. Adjusted operating margin, which excludes specified items, declined 120 basis points to 13.1%. Higher raw-material costs, selling and administrative expenses, and advertising and consumer-promotion costs weighed on the adjusted measure; pricing and manufacturing productivity provided some offsets. Adjusted gross margin edged up 20 basis points to 34.0%. For the business trend, that adjusted margin line is often more useful than the headline reported margin, but readers should review the company’s reconciliation and definitions before comparing it with another company’s measure.

Regional performance also varied. Q2 organic revenue grew 8.4% in Latin America and 7.1% in Asia, Middle East and Africa. North America grew 3.4%, while Europe declined 3.5%; Europe’s volume/mix fell 2.1%. Emerging markets as a group grew 4.4%, compared with 0.7% in developed markets. That makes MDLZ a global portfolio story: strong regions may help offset softness elsewhere, but the aggregate can still conceal weakness in a large market or category.

See the full Mondelez Q2 2026 earnings release and the company’s Form 10-Q for the quarter ended June 30, 2026 for definitions, tables, and reconciliations.

How to compare the investment choices

Investor priorityWhat may fitMain trade-off to verify
Current incomeReview the quarterly dividend and free-cash-flow outlookDividend growth does not remove earnings, input-cost, or valuation risk
Longer-term growthTrack emerging-market sales, brand investment, and volume/mixGrowth may require advertising and promotions, and margins can lag revenue
Lower uncertaintyWait for another quarter of adjusted-margin and volume evidenceMore confirmation may mean buying after a price recovery
Value disciplineCompare price with normalized earnings and cash flowGAAP EPS can be distorted by one-off and mark-to-market items

For an income-focused investor: Mondelez declared a quarterly dividend of $0.52 per share in August, a 4% increase from the prior rate, payable October 14 to holders of record September 30. At the October 6 close, that is roughly a 3.5% indicated annual yield if the quarterly rate were repeated for four quarters. The yield is a simple calculation, not a promise; future dividends require board approval and the stock price changes the yield. Investors prioritizing income should compare the dividend with free cash flow and debt needs, not just the percentage yield. The company’s Q2 update projected about $3 billion in 2026 free cash flow, but that remains guidance and may change.

For a growth-oriented investor: the case rests on sustained organic sales and a healthier balance between pricing and volume. Q2 volume/mix was positive overall, and emerging markets expanded faster than developed markets. But one quarter cannot establish a long-run growth rate. Check whether volume remains positive across regions, whether market share holds, and whether the company can keep investing in brands while improving adjusted profit. High promotion spending could support near-term demand while reducing profitability.

For a cautious investor: waiting for the next report to show that adjusted operating margins have stabilized may reduce the risk of treating a short-term rebound as confirmation. The cost is opportunity: if investors begin to price in margin recovery before the data arrive, the share price could rise first. A cautious approach can still be active by defining the evidence needed—such as improving constant-currency adjusted EPS, better volume/mix in weaker regions, and a credible explanation of cocoa and other input costs—rather than waiting for a particular price alone.

What drove the October chart—and what it cannot tell you

The price path was choppy after Q2. MDLZ closed at $64.99 on July 29, then at $60.25 on September 25 and $57.82 on September 30, before rebounding to $59.46 on October 6. From the July 29 close to October 6, the price-only change was approximately negative 8.5%. This window includes multiple market sessions and does not isolate the effect of any single company event. Price return also excludes dividends. Use the chart as a record of changing market expectations, not as proof that cocoa costs, consumer demand, or margins have improved or deteriorated.

For a practical comparison, check four things together:

Guidance sets the hurdle for the next leg

After Q2, Mondelez raised its 2026 organic net revenue outlook to at least 2% growth. It maintained its outlook for adjusted EPS growth of flat to 5% on a constant-currency basis and expected approximately $3 billion in free cash flow. The company estimated currency translation would add about 2 percentage points to reported net-revenue growth and $0.05 to adjusted EPS, based on exchange rates published July 17. Management also cautioned that the outlook faced greater-than-usual geopolitical, trade, regulatory, and commodity-price volatility.

These figures give investors a scorecard, not a guarantee. A company can meet an organic-sales target while earnings lag if raw-material expenses, advertising, or currency move against it. Conversely, reported EPS might improve because of non-operating comparisons even if underlying margins have not recovered. When the next results are released, compare actuals against the outlook on the same accounting basis, and note whether management changes the forecast or explains a temporary variance.

A final self-check before acting

Before interpreting MDLZ’s next price move, write down which investor goal matters most: income, growth, valuation, or reduced uncertainty. Then check whether the thesis depends on one short-term stock bounce, one unusually strong reported EPS comparison, or an assumption that cocoa and other input costs will fall. The evidence is more convincing when organic revenue, volume/mix, adjusted margins, and cash flow point in the same direction over more than one reporting period.

MDLZ may suit investors who value a global branded-snacks portfolio and can tolerate commodity, currency, and regional-demand swings. A yield-focused buyer should stress-test cash coverage; a growth buyer should require durable volume and margin evidence; and a cautious buyer may prefer to wait for confirmation while accepting that the share price can move before the data do. None of these approaches is best for everyone. The useful test is whether the choice fits the investor’s time horizon and whether the next published results support the assumptions behind it.

Sources and data notes

Historical closing-price comparisons in this article are price-only observations through October 6, 2026 and are not a live quote. Financial information reflects the Q2 2026 release and outlook available on October 7, 2026. This is educational analysis, not individualized investment advice.